Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 22 May, 2020

Bank of NY Mel Corp

Form 8.3 - Willis Towers Watson plc

RNS Number : 8001N
Bank of New York Mellon Corp. (The)
22 May 2020
 

Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing 1)

The Bank of New York Mellon Corporation and its subsidiaries, 1.

The Bank of New York Mellon, 2. BNY Mellon Investment Adviser, Inc., 3. Mellon Investments Corporation, 4. BNY Mellon Trust of Delaware, 5. BNY Mellon, National Association, 6. Lockwood Advisors, Inc., 7. Pershing LLC., 8. BNY Mellon Securities Corporation, 9. BNY Mellon Capital Markets, LLC

Companydealtin

Willis Towers Watson plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.000304635 ordinary shares

Date dealing

21 May 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

1,287,958  1.00%

 

(2) (other options)

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

1,287,958  1.00%

 

             

 

 

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   3)

Classofrelevantsecurity:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

 

 

 

(2) (other options)

 

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

 

 

             

Ap20

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit (Note

Sale

Purchase

Purchase

Purchase

Sale

1,771

1,771

733

21

96

USD 200.16

USD 200.16

USD 200.16

USD 201.64

USD 201.86

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g.

Natureoftransaction

(Note

Numberofrelevantsecurities

(Note

Priceperunit

(Note

 

 

 

 

 

(c)  Options transactions in respect of existing relevant securities

 

(i)  Writing, selling, purchasing or varying

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature transaction

(Note

Details

Price unit

(if applicable) (Note 5)

 

 

 

Ap21

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and 

any other person relating to the voting rights of any relevant securities under any option referred to 

on   this   form   or   relating   to   the   voting   rights   or   future   acquisition   or   disposal   of   any  relevant securities to 

which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

  None

 

 

 

 

Is a Supplemental Form 8 attached?    9)    No

 

Dateofdisclosure

22 May 2020

name

Kevin Lockhart

Telephone number

516-338-3283

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

 

If aconnectedEFM,statenatureofconnection (Note 10)

 

 

  Ap23


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEFLFFSEVIFFII

a d v e r t i s e m e n t